- Rising Health Costs Push Some Middle-Aged Adults To Skip the Doc Until Medicare
- Even With Dental Insurance, You Still Could Face a Large Bill
- Don't Forget This: Study Shows Cannabis Exacts a Toll on Your Memory
- Want To Stress Less? Start With These Everyday Habits
- Journalists Shine Light on Out-of-Reach Insurance Prices, AI’s Role in Claims Disputes, and Susie Wiles
- Arizona behavioral health center adds 10 adolescent beds
- The explosion of the Medicare Advantage special needs plan
- The explosion of the Medicare Advantage special needs plan
- We’re Great Thinkers…But Not Rethinkers
- North Star to cut additional jobs
- North Star to cut additional jobs
- Oregon Governor asks PeaceHealth to delay contract switch: 11 things to know
- 6 Optum updates to know from Q1
- Viewpoint: US nursing workforce faces several risks
- The shifting dental hygiene landscape
- 12 dental insurance updates in 30 days
- ‘The 1980s called’: CMS to phase out fax, mail
- ‘The 1980s called’: CMS to phase out fax, mail
- Aligning IT & clinical teams: How to reduce friction and improve communication
- AI tool targets billing gaps at Kentucky system
- AI in pharmacy: Why pilots stall at hospitals
- 37 recent hospital, health system executive moves
- This ASC startup is wiring AI into the fabric of outpatient surgery
- Springer Nature retracts 38 papers over autism dataset
- Intermountain plans new outpatient clinic
- Legacy Health, Regence BCBS face looming contract expiration
- Meet the COOs of the largest DSOs
- Michigan bills target outpatient fees, CON requirements
- Anesthesia group, lawmakers oppose Medicare cuts to non-opioid pain treatment
- Iowa lifts emergency suspension of transplant surgeon’s license
- Vascular center, physician CEO to pay $4M to settle fraud allegations
- In the Affordability Alphabet Soup of the ACA and EHBs, a Link to Higher Premiums Isn’t Clear-Cut
- 5 cardiologists stepping into leadership roles
- New York organizations partner on intellectual, developmental disabilities campus
- Cincinnati hospital acquires outpatient center for $6M
- CMS final rule aims to axe the fax machine, phase out paper mailing
- 24 profitable health systems in 2025
- How 2 CFOs plan for uncertainty
- Heartland Dental expands with Texas affiliation
- MD Anderson opens colorectal cancer center
- SALT Dental Partners adds Washington practice
- 11 dental school updates to know
- 6 health systems seeking revenue cycle executive directors
- Remarks at The SEC Speaks in 2026: From Kitchen Table to Cap Table—Making Capital Formation Work for Small Businesses
- Integrated care model drives 76% depression improvement in 44 days: Study
- Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds
- Survey Shows More People Struggling To Afford ACA Insurance
- Up to 155,000 COVID Deaths May Not Have Been Counted, Study Finds
- FDA Drops Plan To Ban Tanning Beds for Minors Nationwide
- Idaho bill proposes consolidating dental regulatory oversight
- Washington hospital charts path to preserve primary care
- 4 DSOs making headlines
- 6 state behavioral health policy updates
- 80% of returning ACA enrollees report higher healthcare costs in 2026
- Fitch downgrades HonorHealth’s credit rating
- NYC Health + Hospitals names dentistry, oral surgery leaders
- Mindray North America Enters Ventilator Market
- Mindray North America Enters Ventilator Market
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- With Novo's semaglutide going off patent, Indian drugmakers set to launch their cheaper generics
- Sanofi backs 2 more documentary films about rare blood disorders
- ACIP member's miscommunication on vaccine panel's future adds to confusion after court ruling
- Rhythm's Imcivree scores 'transformative' FDA approval in brain damage-related obesity
- Some Patients With ADHD and Addiction History Missing Out
- Social Media Poses Risks to Children's Mental Health, Review Concludes
- 'Early Bird' Exercisers Get The Most Health Benefits, Study Finds
- Does Closing Your Eyes Help You Hear Better?
- High Blood Pressure Deaths Quadruple Among Young Women, Study Finds
- Meningitis Vaccine Doesn't Protect Gay, Bisexual Men From Gonorrhea, Clinical Trial Concludes
- Oz Escalates Medicaid Fraud Claims Against States After Focus on Minnesota
- Listen: Trump’s NIH ‘Reset’ Is Driving Away Scientists
- ‘How Low Can You Go?’ The Shifting Guidelines for Blood Pressure Control
- Mississippi to fund clinical trials for psychedelic drug
- Lawmakers push bill to boost mental health workforce, diversity
- Florida State partners with behavioral health provider on research
- Utah governor signs hygienist autonomy bill
- UHS CEO: Talkspace deal builds 1st national ‘end-to-end’ behavioral model
- Psychedelic therapy shows no benefit over antidepressants: Study
- What the Health? From KFF Health News: RFK Jr.’s Vaccine Schedule Changes Blocked — For Now
- Verily banks $300M to accelerate AI road map, transitions to independent company
- KFF: ACA plan enrollees report rising costs for 2026 coverage
- Industry Voices—Stop buying AI tools, start designing AI architecture
- CSL warns of supply shortfall, treatment delays for hemophilia gene therapy Hemgenix
- 10K Corewell Health nurses vote to authorize labor strike
- Providence mulling sale of its health plan amid financial pressures
- Fierce Pharma Asia—World's 1st brain chip nod; AZ's cell therapy bet; Astellas-CytomX breakup
- Gut Microbiome May Take Years to Recover From Antibiotic Use
- Prepared Remarks Before SEC Speaks
- The Art and Science of Materiality
- Capital, Choice, and the Pursuit of Happiness: Remarks at The SEC Speaks in 2026
- Novo's Wegovy HD passes muster under FDA national priority voucher program
- Hospital operations begin 2026 with depressed margins amid low volumes, high labor spend
- The Math Behind Eczema Flare-Ups May Finally Add Up
- Male preconception startup Upstream announces donor-matching platform
- Women's health sector could grow to $600B industry by 2030: PwC report
- Democratic senators detail plans to take on 'Big Insurance'
- Both Types Of Diabetes Increase Dementia Risk
- Aldi Recalls Spinach Bites Over Possible Contamination
- Collegium ponies up $650M to gain ADHD drug Azstarys from Corium
- Maryland bill calls for more transparency in pharma's disease awareness campaigns
- After Alfasigma's GSK licensing deal, Lynavoy picks up FDA nod in rare liver disease
- What To Know About Fatty Liver Disease and Why It’s So Common
- Drug Smoking Linked To Surge In Severe Burn Cases
- Thymus Gland Health May Be Key to Long Life and Fighting Cancer
- Premature Menopause Increases Heart Disease Risk
- U.S. Teen Obesity Hits Record Highs While Efforts to Slim Down Drop
- Pesticide Exposure Before Pregnancy Might Risk Newborn Health
- UPDATED: AstraZeneca to build cell therapy manufacturing hub, R&D center in Shanghai
- Many ACA Customers Are Paying Higher Premiums. Most Blame Trump and Republicans, Poll Finds.
- Lawmakers Seek To Protect Crisis Pregnancy Centers as Abortion Clinic Numbers Shrink
- CDMO Axplora to pump $60M into Italian complex API plant
- Pfizer eyes earlier Talzenna use after phase 3 prostate cancer win
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- Turquoise Health raises $40M to power healthcare contracts, payments
- To tackle healthcare costs, representatives weigh curbs on provider consolidation
- A look at Highmark's specialty pharmacy partnership with Free Market Health
- AD/PD 2026: New data highlight potential cost-effectiveness of confirmatory AD blood testing in U.S. diagnostic pathways
- With downgrade, HSBC casts doubt about Lilly's 'stairway to heaven' trajectory
- TrumpRx's 'world's lowest' drug price claims fall short in global comparison: NYT
- Study Finds Little Proof Cannabis Helps Most Mental Health Conditions
- Meningitis Outbreak Tied to Students Leaves 2 Dead and 11 Sick in England
- J&J, Protagonist's 'game-changer' once-daily psoriasis pill Icotyde nabs FDA approval
- Belly Fat Linked To Heart Failure Risk
- Women More Likely To Survive Cancer Than Men — At A Cost
- BMS brings 'Emily in Paris' star and cancer survivor Ashley Park aboard campaign honoring oncologists
- Sandoz expands biosim collab with Samsung Bioepis, sets sights on Takeda's Entyvio
- Ultra-Processed Foods Linked To Heart Attack, Stroke, Cardiac Arrest
- E. Coli Outbreak Tied To Raw Cheddar Cheese Sickens 7 People
- The Sunshine Vitamin and COVID: New Study Finds Mixed Results for Recovery
- Too Much Smartphone Use Linked to Disordered Eating in Teens
- Shingles Vaccine Protects Heart Failure Patients From Heart Attack, Stroke
- White House Chief of Staff Susie Wiles Diagnosed With Early Breast Cancer
- Gates-backed TerraPower Isotopes blueprints $450M plant to supply next wave of radiopharmaceuticals
- Regulation Crypto Assets: A Token Safe Harbor
- The Last Chapter in the Book of Howey
- Payers, hospitals pan CMS' plan to bring non-network plans to ACA exchanges
- Optum Real and Suki build out collaboration to tackle payment challenges as R1 teams with AI scribe Heidi
- Indiana homes in on life sciences with $1B growth strategy, plan to create 100K jobs
- Moody's: Insurers' 2026 outlook is negative as cost pressures continue to batter industry
- GSK's management of Flovent allowed it to 'game the system': Hassan
- Allina Health to join Sutter Health in $26B proposed transaction
- Norovirus Sickens Close to 200 People on Caribbean Cruise
Before civilization became unglued in Minnesota, the massive increase in PPACA insurance policy premiums was the fixation in Washington. Those premiums haven't come down or disappeared as a political issue. Joel White of the Council for Affordable Health Coverage (CAHC) has an explanation:
High ACA Premiums Aren’t an Accident, It’s a Business Model for Insurers
By Joel White - January 27, 2026Health care costs are crushing Americans, and Washington keeps pretending it’s a mystery. It isn’t. Obamacare didn’t just fail to give Americans access to care they could afford; it redesigned the system to guarantee insurance companies huge profits. And year after year, Democrats have doubled down on that design, protecting insurers while families pay more for less care.
Affordability is the number one problem in American health care. It’s a problem that crosses party lines. Last week, President Trump introduced The Great Healthcare Plan, designed to lower costs and increase access to care. Health care costs are so out of control that the typical American family will spend 40 percent of their income just on health insurance premiums by 2032. That is not sustainable for any American.
Since the Affordable Care Act (ACA) was enacted, premiums in the individual market have surged by 168 percent, far outpacing employer-sponsored plans, which rose 70 percent, and inflation, at about 40 percent. This year alone, the average ACA family premium is projected to exceed $27,000. Deductibles have nearly doubled as well, meaning families are paying more every month and still pay thousands of dollars in out-of-pocket costs before their coverage even kicks in. In 2026, the deductible for the most popular plan is more than $5,000.
Democrats often respond to this crisis with a familiar solution: more spending. But subsidies haven’t fixed the problem; they’ve made it worse.
Under the ACA, subsidies go to insurance companies and can only be used toward the most expensive plans on the market. As premiums rise, subsidies follow dollar for dollar. Insurers set the prices, and taxpayers guarantee the revenue. Today, 93 percent of ACA enrollees receive subsidies, and taxpayer subsidies per enrollee have increased 56 percent since 2014. According to the Joint Economic Committee, only about one-third of those subsidy dollars directly benefit consumers.
The rest flows straight into insurance company balance sheets.
This is not an accident; it’s an incentive structure. Expanding subsidies and enrolling more people doesn’t pressure insurers to compete or lower prices; it rewards them for charging more. Every premium hike is matched with more taxpayer money. Democrats celebrate higher enrollment numbers while ignoring the reality that the system financially depends on rising costs.
At the same time, the ACA’s anti-market structure has fueled widespread consolidation. One or two insurance companies control the market in most states, pushing out smaller insurers that can’t survive in a system that rewards scale, political influence, and administrative complexity over efficiency and consumer choice.
As competition disappears, so does access to care. Eighty-three percent of enrollees are in narrow-network plans, which limit the hospitals and physicians they can access. Obamacare networks typically include fewer than half of all care providers in an area. This is especially concerning for patients with serious or complex conditions. Families routinely face restricted formularies, denied claims, and endless prior-authorization hurdles. According to the Kaiser Family Foundation, 58 percent of insured Americans experienced a problem with their insurer in the past year, and 73 million claims were denied.
Meanwhile, to avoid Obamacare’s cap on insurance profits, insurance companies have been busy buying hospitals, physician groups, and pharmacies, and paying them more to earn higher profits on services. UnitedHealth Group now generates roughly 42 percent of its revenue, or $136 billion, from internal transactions between its insurance arm and the providers and pharmacy benefit managers it owns. That isn’t care coordination; it’s a monopoly designed to extract profit at every step.
And the profits are staggering. In a recent year, the largest insurers earned more than $71 billion. Insurance CEOs collected nearly $150 million in compensation – all while premiums and out-of-pocket costs kept rising for consumers. The ACA has become a massive transfer of taxpayer dollars to private insurance companies, propped up by policies that Democrats refuse to question.
This is the uncomfortable truth: Democrats claim to stand with patients, but their health care policies protect insurers. They defend a system that rewards size, spending, and consolidation, then act surprised when costs spiral out of control. Every subsidy expansion, every enrollment push, every refusal to introduce real competition locks Americans deeper into a system that treats patients like piggybanks.
There is another path. Congress needs to restore competition by breaking up the insurance and health system monopolies. We need full transparency on prices and quality. If insurers, hospitals, and other service providers refuse to provide prices up front, patients shouldn’t be charged. Consumers should be able to choose any plan that works for them and bring the subsidy with them. If the plan they pick costs less than the subsidy, the difference should be deposited in a Health Savings Account. Insurers would compete for consumers, versus patients being at the mercy of big conglomerates through realigned incentives that ensure health plans and providers only succeed when patients do.
Until that happens, ACA premiums will keep increasing, subsidies will forever increase, insurers will keep cashing in, and working families will keep paying the price for a health care system designed to put profits over patients.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















